GENFIT Announces Positive EMA Opinion on Iqirvo® for Primary Biliary Cholangitis
Jul 26, 2024
Iqirvo Stock Market Invest
Ipsen's Iqirvo® Granted Accelerated FDA Approval for Primary Biliary Cholangitis Treatment
Jun 11, 2024